Posaconazole is non-inferior to voriconazole for primary treatment of invasive aspergillosis
1. Posaconazole was non-inferior to voriconazole with respect to all-cause mortality at day 42 (15% vs. 21%, respectively). 2. Incidence ...
1. Posaconazole was non-inferior to voriconazole with respect to all-cause mortality at day 42 (15% vs. 21%, respectively). 2. Incidence ...
1. In immunocompromised patients with invasive aspergillosis, treatment with voriconazole was found to be superior to amphotericin B in achieving ...
Image: PD 1. Hematopoeitic stem-cell transplant (HSCT) patients who received donor cells with a PTX3 haplotype of h2/h2 had an ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.